Search Count: 9
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase In Complex With 3-Hydroxy-1-Methyl Pyrazole Derivatives
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.95 Å Release Date: 2026-04-01 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, A1JWR |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2026-04-01
Ligands: FMN, ORO, A1JWR
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase In Complex With 3-Hydroxy-1-Methyl Pyrazole Derivatives
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2026-04-01 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, A1JWQ |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2026-04-01
Ligands: FMN, ORO, A1JWQ
 |
Crystal Structure Of Human Dihydroorotate Dehydrogenase In Complex With The Inhibitor 2-Hydroxy-N-(2-Isopropyl-5-Methyl-4-(Pyridin-4-Yloxy)Phenyl)Pyrazolo[1,5-A]Pyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-06-19 Classification: FLAVOPROTEIN Ligands: FMN, ORO, YMH, ACT, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-19
Ligands: FMN, ORO, YMH, ACT, SO4
 |
Crystal Structure Of Human Dihydroorotate Dehydrogenase In Complex With The Inhibitor 2-Hydroxy-N-(2-Ispropyl-5-Methyl-4-Phenoxyphenyl)Pyrazolo[1,5-A]Pyridine-3-Carboxamide.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-10-12 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, IEQ, P6G, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-10-12
Ligands: FMN, ORO, IEQ, P6G, ACT
 |
M. Tuberculosis Salicylate Synthase Mbti In Complex With Salicylate And Mg2+
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2020-07-15 Classification: LYASE Ligands: SO4, MG, ACT, SAL |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2020-07-15
Ligands: SO4, MG, ACT, SAL
 |
M. Tuberculosis Salicylate Synthase Mbti In Complex With 5-(3-Cyanophenyl)Furan-2-Carboxylate
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2020-07-01 Classification: LYASE Ligands: M83, CL |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2020-07-01
Ligands: M83, CL
 |
M. Tuberculosis Salicylate Synthase Mbti In Complex With Ba2+
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2020-07-01 Classification: LYASE Ligands: GOL, PO4, CL, BA |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2020-07-01
Ligands: GOL, PO4, CL, BA
 |
Crystal Structure Of Human Beta-Tryptase Complexed With A Synthetic Inhibitor With A Tropanylamide Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2012-03-14 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 0GX, CO3 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-03-14
Ligands: 0GX, CO3
 |
Cellular Inhibition Of Checkpoint Kinase 2 And Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor Pv1019
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2009-09-22 Classification: TRANSFERASE Ligands: D1A, MG, NO3, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-09-22
Ligands: D1A, MG, NO3, EDO